ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645317 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645317; 2) Community: the network communities that were significantly associated with the response to NSC 645317; 3) Molecule: the relationships between components within communities and NSC 645317; 4) MDR: the compounds that were significantly associated with the NSC 645317.

NSC Compound Enrichment Correlation
NSC 681641 Camptothecin Derivative 0.00741876119839028 0.19803115
NSC 83950 A 050165L302 0.00741876119839028 0.026892409
NSC 626162 Discorhabdin C . TFA 0.00741876119839033 0.33433221
NSC 631136 Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.00741876119839033 0.40457353
NSC 635449 Copper, chloro[2-[1-(2-pyridinyl)ethylidene][N,N-dipropyl-hydrazinecarbothioamidato-N,N,S]- 0.00741876119839033 0.43033556
NSC 637921 1H-Pyrazole-1-propanamide, 3,5-diphenyl- N-(4-methoxyphenyl)-4-[(4-methylphenyl)azo]-.beta.-oxo- 0.00741876119839033 -0.38478056
NSC 638241 Null 0.00741876119839033 0.62065697
NSC 639520 Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.00741876119839033 0.48739344
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.00741876119839033 0.39739132
NSC 670687 Null 0.00770426557728501 0.33236275
Total:127  Current:37    [First] [Prev] [Next] [Last]